210 related articles for article (PubMed ID: 15500836)
1. Evaluation of pressor sensitivity to norepinephrine infusion in dogs with iatrogenic hyperadrenocorticism. Pressor sensitivity in dogs with hyperadrenocorticism.
Martínez NI; Panciera DL; Abbott JA; Ward DL
Res Vet Sci; 2005 Feb; 78(1):25-31. PubMed ID: 15500836
[TBL] [Abstract][Full Text] [Related]
2. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism.
Ortega TM; Feldman EC; Nelson RW; Willits N; Cowgill LD
J Am Vet Med Assoc; 1996 Nov; 209(10):1724-9. PubMed ID: 8921029
[TBL] [Abstract][Full Text] [Related]
3. Urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs.
Feldman EC; Mack RE
J Am Vet Med Assoc; 1992 Jun; 200(11):1637-41. PubMed ID: 1624338
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism.
Klose TC; Creevy KE; Brainard BM
J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):625-32. PubMed ID: 22316255
[TBL] [Abstract][Full Text] [Related]
5. Retrospective evaluation of the effect of trilostane on insulin requirement and fructosamine concentration in eight diabetic dogs with hyperadrenocorticism.
McLauchlan G; Knottenbelt C; Augusto M; Helm J; McGrotty Y; Ramsey I
J Small Anim Pract; 2010 Dec; 51(12):642-8. PubMed ID: 21121919
[TBL] [Abstract][Full Text] [Related]
6. Determination of renal vascular resistance in dogs with diabetes mellitus and hyperadrenocorticism.
Novellas R; de Gopegui RR; Espada Y
Vet Rec; 2008 Nov; 163(20):592-6. PubMed ID: 19011245
[TBL] [Abstract][Full Text] [Related]
7. Quantitative CT assessment of bone mineral density in dogs with hyperadrenocorticism.
Lee D; Lee Y; Choi W; Chang J; Kang JH; Na KJ; Chang DW
J Vet Sci; 2015; 16(4):531-42. PubMed ID: 26040613
[TBL] [Abstract][Full Text] [Related]
8. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
Peterson ME; Altszuler N
Am J Vet Res; 1981 Nov; 42(11):1881-3. PubMed ID: 7199880
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).
Behrend EN; Kooistra HS; Nelson R; Reusch CE; Scott-Moncrieff JC
J Vet Intern Med; 2013; 27(6):1292-304. PubMed ID: 24112317
[TBL] [Abstract][Full Text] [Related]
10. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism.
Peterson ME; Altszuler N; Nichols CE
Res Vet Sci; 1984 Mar; 36(2):177-82. PubMed ID: 6371957
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic efficacy of plasma ACTH-measurement by a chemiluminometric assay in canine hyperadrenocorticism].
Zeugswetter F; Pagitz M; Hittmair K; Schwendenwein I
Schweiz Arch Tierheilkd; 2011 Mar; 153(3):111-6. PubMed ID: 21360448
[TBL] [Abstract][Full Text] [Related]
12. Effect of canine hyperadrenocorticism on coagulation parameters.
Rose L; Dunn ME; Bédard C
J Vet Intern Med; 2013; 27(1):207-11. PubMed ID: 23278831
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase 1 and butyrylcholinesterase in dogs with hyperadrenocorticism.
Tvarijonaviciute A; Caldin M; Martinez-Subiela S; Tecles F; Pastor J; Ceron JJ
Vet J; 2015 Feb; 203(2):262-3. PubMed ID: 25555340
[TBL] [Abstract][Full Text] [Related]
14. Concurrent hyperadrenocorticism and diabetes mellitus in dogs.
Miceli DD; Pignataro OP; Castillo VA
Res Vet Sci; 2017 Dec; 115():425-431. PubMed ID: 28759861
[TBL] [Abstract][Full Text] [Related]
15. Characterization of thrombelastography over time in dogs with hyperadrenocorticism.
Kol A; Nelson RW; Gosselin RC; Borjesson DL
Vet J; 2013 Sep; 197(3):675-81. PubMed ID: 23838206
[TBL] [Abstract][Full Text] [Related]
16. Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis.
Hess RS; Kass PH; Ward CR
J Am Vet Med Assoc; 1998 Jun; 212(12):1889-91. PubMed ID: 9638187
[TBL] [Abstract][Full Text] [Related]
17. Assessment of corticosteroid-induced alkaline phosphatase isoenzyme as a screening test for hyperadrenocorticism in dogs.
Solter PF; Hoffmann WE; Hungerford LL; Peterson ME; Dorner JL
J Am Vet Med Assoc; 1993 Aug; 203(4):534-8. PubMed ID: 8407509
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.
Vaughan MA; Feldman EC; Hoar BR; Nelson RW
J Am Vet Med Assoc; 2008 May; 232(9):1321-8. PubMed ID: 18447776
[TBL] [Abstract][Full Text] [Related]
19. Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism.
Lien YH; Hsiang TY; Huang HP
Acta Vet Scand; 2010 Nov; 52(1):61. PubMed ID: 21070672
[TBL] [Abstract][Full Text] [Related]
20. The effects of vasopressor and vasodilator on hemodynamic energy in terms of surplus hemodynamic energy.
Lim CH; Yang S; Son HS; Lee JJ; Yoon JR; Lee SH; Lee HW; Sun K
ASAIO J; 2008; 54(5):534-7. PubMed ID: 18812748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
